Participations à des congrès et colloques internationaux (42)
10.
Dubruille, S., Libert, Y., Merckaert, I., Reynaert, C., Vandenbossche, S., Roos, M., Bron, D., & Razavi, D. (2015). Cognitive impairment predicts two-years total mortality in elderly onco-surgical patients. Abstracts of the Annual Conference of the International Society of Geriatric Oncology(6), 13-27 Abstract session presented at (2015: Prague).12.
De Wilde, V., Spilleboudt, C., Racapé, J., Lewalle, P., Bron, D., Cohen, J., Maury, S., Abramowicz, M., & Le Moine, A. (2014). Long (GT)n repeat in the promoter region of heme oxygenase-1 is associated with severe graft-versus-host disease. Poster présenté à la conférence 29th General Annual Meeting Belgian Hematological Society (29: 2014).13.
Borghgraef, C., Libert, Y., Beguin, Y., Bron, D., Dubruille, S., Etienne, A.-M., Reynaert, C., Doyen, C., Straetmans, N., Van Den Neste, E., & Razavi, D. (2014). Altered Cognitive Compensatory Mechanisms in an Elderly Cancer Patient Population Undergoing Chemotherapy: A Longitudinal Study. In Abstracts of the 16th IPOS World Congress of Psycho-Oncology: Vol. 23 (p. 146) Psycho-Oncology.14.
Dubruille, S., Libert, Y., Roos, M., Vandenbossche, S., Collard, A., Meuleman, N., Maerevoet, M., Etienne, A.-M., Reynaert, C., Razavi, D., & Bron, D. (2014). Prognostic Value of Neuro-Psychological and Biological Factors in Clinically Fit Older Patients with Hematological Malignancies. Abstracts of the 56th American Society of Hematology Annual Meeting. Vol. 124 Abstract session presented at 56th American Society of Hematology Annual Meeting.15.
Dubruille, S., Libert, Y., Roos, M., Vandenbossche, S., Meuleman, N., Maerevoet, M., Razavi, D., & Bron, D. (2014). Prognostic value of neuropsychological and biological factors in older patients with hematological malignancies admitted to receive chemotherapy. In Abstracts of the 19th Congress Of The European Hematology Association: Vol. 99 (p. 215) Haematologica.16.
Dubruille, S., Libert, Y., Roos, M., Vandenbossche, S., Meuleman, N., Maerevoet, M., Razavi, D., & Bron, D. (2014). The respective value of the G8 screening and the Comprehensive Geriatric Assessment (CGA) for the identification of vulnerable older patients with hematological malignancies susceptible to benefit from chemotherapy. Abstracts of the 29th General Annual Meeting of the Belgian Hematological Society Abstract session presented at 29th General Annual Meeting of the Belgian Hematological Society(2014: Gent)17.
Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Triptorelin to prevent chemotherapy-induced ovarian failure in lymphoma patients: a prospective randomized study. Paper session presented at 3rd Wold Congress of the ISFP (International Society for Fertility Preservation) (7-9 November 2013: Valencia, Spain).18.
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., De Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., Veys, I., Haibe-Kains, B., Singhal, S. K., Michiels, S., Rothé, F., Salgado, R., Duvillier, H., Ignatiadis, M., Desmedt, C., Bron, D., Larsimont, D., Piccart-Gebhart, M., Sotiriou, C., & Willard-Gallo, K. (2013). CXCL13-producing follicular helper CD4+ T Cells in extensively-infiltrated breast cancer signal an organized immune response and predict survival. Paper session presented at Roche - Nature Medicine Immunology Symposium 2013: Host Immunity to Cancer and Chronic Viral Infections (April 28-30, 2013: Lucerne, Switzerland).19.
Delafaille, S., Kolivras, A., Christoffersen, S., Metz, T., Bron, D., & André, J. (2013). Efficiency and cutaneous adverse effects of alemtuzumab (CAMPATH: anti-CD-52 monoclonal antibody) in a patient with T-cell prolymphocytic leukemia and erythroderma. Société Royale Belge Dermatologie et Vénérologie 2013 Abstract session presented at 20.
Dubruille, S., Bron, D., Roos, M., Vandenbossche, S., Meuleman, N., Maerevoet, M., Razavi, D., & Libert, Y. (2013). The respective usefulness of the G8 and a comprehensive geriatric assessment (CGA) to predict intolerance to chemotherapy and survival of fit and vulnerable older patients with hematological malignancies. Abstracts of the SIOG 2013 Annual Conference. Vol. 4 (1 ed., p. 56) Abstract session presented at SIOG 2013 Annual Conference "Multidisciplinary Approach towards Personalized Treatments"(Copenhagen).21.
Dubruille, S., Maerevoet, M., Roos, M., Vandenbossche, S., Meuleman, N., Libert, Y., & Bron, D. (2013). G8 as a screening tool for older patients with malignant hemopathies: A surrogate for CGA? Abstracts of the 28th General Annual Meeting of the Belgian Hematological Society Abstract session presented at 28th General Annual Meeting of the Belgian Hematological Society(Gent)